Sarepta Therapeutics Crashes After A Third Gene Therapy Patient Dies - Investor's Business Daily
Business
Sarepta stock crashed Friday wiping out almost all of the gains tied to its restructuring plans after a third recipient of one of its gene therapies died. According to analysts and several media rep? [+4228 chars]

Leave A Comment

Comments are moderated and may take time to appear.

Comments

No comments yet. Be the first to comment!

Popular Categories

Stay Connected

Loading...